FDA approves Medtronic drug-coated stent

The FDA has granted Medtronic approval to market its Endeavor drug-coated stent in the U.S. The device is expected to compete with stents from Boston Scientific Corp. and Johnson & Johnson in the $2 billion market, which declined last year due to safety concerns. The company has increased its sales staff and began distributing the product Friday.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.) · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA